External Evaluation of the US President’s Malaria Initiative (PMI)
The US President’s Malaria Initiative (PMI) is an interagency initiative led by USAID and implemented together with CDC. It is overseen by a U.S. Global Malaria Coordinator and an Interagency Steering Group made up of representatives of USAID, CDC/HHS, the Department of State, the Department of Defense, the National Security Council, and the Office of Management and Budget. The goal of PMI is to reduce malaria-related deaths by 50 percent in 15 countries that have a high burden of malaria through proven curative and preventive interventions, including insecticide-treated nets (ITNs), indoor residual spraying (IRS), intermittent preventive treatment for pregnant women (IPTp), and artemisinin-based combination therapies (ACTs).
In late May 2011, PMI commissioned an external Evaluation Team to review the first five years (FY06-FY10) of PMI’s activities. The evaluation involved extensive document review, key informant interviews in Washington, Atlanta and Geneva, country site visits (Angola, Malawi, Rwanda, Senegal, and Zambia) and electronic and telephone interviews with malaria program personnel from the other ten PMI focus countries.
The External Evaluation was organized around six core objectives:
Objective 1: Evaluate how PMI leadership, management and resources have advanced the initiative’s goals and provide recommendations for improved performance.
Objective 2: Evaluate the performance of the PMI in terms of putting its four Core operating principles into practice. Core principles include:
- Use of a comprehensive, integrated package of proven prevention and treatment interventions
- Strengthening of health systems and integrated maternal and child health programs
- Commitment to strengthen NMCPs and build capacity for country ownership of national malaria control efforts
- Close coordination with international and in-country partners
Objective 3: Evaluate the wider partnership environment in which PMI operates at both global and country levels.
Objective 4: Assess progress toward program outcomes and impact (with a focus on assessing the quality of the evaluation and methods used to generate the outputs and outcomes data).
Objective 5: Assess operations research activities
Objective 6: Use evidence as generated from the evaluation to make actionable recommendations for improvement of PMI and for USG involvement in global health initiatives.
|Principal Investigator||Jonathon Simon|
|Boston University Co-Investigators||Kojo Yeboah-Antwi, Bram Brooks|
|Collaborators||Allan Schapira (WHO Consultant), Mohammadou Kabir Cham (WHO Consultant), Rosemary Barber-Madden (Columbia University Consultant)|
|Country(ies)||Angola, Malawi, Rwanda, Senegal, and Zambia|
|Dates of Research||2011|